Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of metastatic disease of the central nervous system
Craig Nolan, Lisa M. DeAngelis
Handbook of clinical neurology (2018), pp. 3-23
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Immunotherapy: an emerging modality to checkmate brain metastasis
Aatiya Ahmad, Parvez Κhan, Asad Rehman, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain Metastasis
Elham Karami, Hany Soliman, Mark Ruschin, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 59
TME-targeted approaches of brain metastases and its clinical therapeutic evidence
Ibrar Muhammad Khan, Safir Ullah Khan, Hari Siva Sai Sala, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis
Rafel Fuentes, Dimelza Osorio, José Expósito Hernández, et al.
Cochrane library (2018) Vol. 2018, Iss. 8
Open Access | Times Cited: 49
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases
Bihong T. Chen, Taihao Jin, Ningrong Ye, et al.
Magnetic Resonance Imaging (2020) Vol. 69, pp. 49-56
Open Access | Times Cited: 45
Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor
Saber Amin, Michael J. Baine, Jane L. Meza, et al.
JAMA Network Open (2020) Vol. 3, Iss. 9, pp. e2015444-e2015444
Open Access | Times Cited: 40
Fully Automated MR Detection and Segmentation of Brain Metastases in Non‐small Cell Lung Cancer Using Deep Learning
Stephanie T. Jünger, Ulrike Cornelia Isabel Hoyer, Diana Schaufler, et al.
Journal of Magnetic Resonance Imaging (2021) Vol. 54, Iss. 5, pp. 1608-1622
Open Access | Times Cited: 34
Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion
Jessica Waibl Polania, Alexandra Hoyt-Miggelbrink, William H. Tomaszewski, et al.
Immunity (2024)
Open Access | Times Cited: 5
The Management of Brain Metastases—Systematic Review of Neurosurgical Aspects
Martin Proescholdt, Petra Schödel, Christian Doenitz, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1616-1616
Open Access | Times Cited: 30
Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data
Ana Delia Ramos-Guerra, Benito Farina, Jaime Rubio, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood–brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis
Samah A. Jassam, Zaynah Maherally, Keyoumars Ashkan, et al.
Journal of Neuro-Oncology (2019) Vol. 143, Iss. 3, pp. 405-415
Open Access | Times Cited: 35
Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy
Ji Zhang, Juebin Jin, Yao Ai, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 22
Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis
Ye Li, Xinna Lv, Bing Wang, et al.
European Journal of Radiology (2022) Vol. 155, pp. 110499-110499
Closed Access | Times Cited: 14
Exosomes and Brain Metastases: A Review on Their Role and Potential Applications
Filipa D. Oliveira, Miguel A. R. B. Castanho, Vera Neves
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10899-10899
Open Access | Times Cited: 20
Central Nervous System Metastases
Edwin Nieblas‐Bedolla, Jeffrey Zuccato, Harriet M. Kluger, et al.
Hematology/Oncology Clinics of North America (2021) Vol. 36, Iss. 1, pp. 161-188
Closed Access | Times Cited: 18
Survival outcomes after whole brain radiotherapy for brain metastases in older adults with newly diagnosed metastatic small cell carcinoma: A national cancer database (NCDB) analysis
Paul Renz, Shaakir Hasan, Rodney E. Wegner
Journal of Geriatric Oncology (2019) Vol. 10, Iss. 4, pp. 560-566
Open Access | Times Cited: 20
Diagnosis, treatment, and survival in spinal dissemination of primary intracranial glioblastoma: systematic literature review
Christina Huang Wright, James Wright, Louisa Onyewadume, et al.
Journal of Neurosurgery Spine (2019) Vol. 31, Iss. 5, pp. 723-732
Closed Access | Times Cited: 20
Neuro-Ophthalmic Manifestations of Intracranial Malignancies
Christopher R. Dermarkarian, Ashwini Kini, Bayan Al Othman, et al.
Journal of Neuro-Ophthalmology (2020) Vol. 40, Iss. 3, pp. e31-e48
Open Access | Times Cited: 19
Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy
Aurélien Corroyer‐Dulmont, Samuel Valable, Jade Fantin, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type
Saber Amin, Michael J. Baine, Jane L. Meza, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments
Stephanie T. Jünger, Petra Schödel, Daniel Rueß, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3618-3618
Open Access | Times Cited: 12
Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases
Xinna Lv, Ye Li, Bing Wang, et al.
European Journal of Radiology Open (2024) Vol. 12, pp. 100548-100548
Open Access | Times Cited: 1
Comparison of clinical and MRI features of brain metastases between ALK+ and ALK‐ NSCLC
Xiaolu Ren, Xuting Zhang, Xiaoyan Lei, et al.
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 1
The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival
Anders W. Erickson, Sunit Das
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 10
Neuro-ophthalmic manifestations of cancer: a narrative review
Timothy M. Janetos, Nicholas J. Volpe, Shira S. Simon
Chinese Clinical Oncology (2022) Vol. 11, Iss. 3, pp. 25-25
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top